Zobrazeno 1 - 4
of 4
pro vyhledávání: '"D. M. Rocha Castellanos"'
Autor:
A Abdul Razzack, D. M. Rocha Castellanos, M Pusa, Suveenkrishna Pothuru, Yasar Sattar, M Fernando Perez Paz, A Lopez Mendez, V Patel
Publikováno v:
European Journal of Preventive Cardiology. 28
Funding Acknowledgements Type of funding sources: None. Background- Patients with small Abdominal Aortic Aneurysms are managed with surveillance as there is currently insufficient evidence to recommend surgical aneurysm repair. Hence, there is a dire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa1754b02e2137e02b8260fe21fd8a9e
https://doi.org/10.1093/eurjpc/zwab061.126
https://doi.org/10.1093/eurjpc/zwab061.126
Autor:
K Theja Reddy, Farah Yasmin, Adnan Mustafa, S Mandava, WX Gopar Franco, Nileshkumar J. Patel, D. M. Rocha Castellanos, Patel, H Mehmood Lak, A Abdul Razzack, R Kumar Ochani, S Adeel Hassan, Suveenkrishna Pothuru
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: None. Background The current guidelines recommend a trial of antiarrhythmic drugs (AAD) before ablation is considered. However, the concept "first do no harm" plays an integral role in the management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29f874588086bdf8db903eac7cf4b37a
https://doi.org/10.1093/europace/euab116.259
https://doi.org/10.1093/europace/euab116.259
Autor:
K Theja Reddy, Yasar Sattar, Junaid Arshad, G Lilian Contreras Gallegos, D. M. Rocha Castellanos, D Missael Rocha Castellanos, S Mandava, Suveenkrishna Pothuru, A Sanchez Alfaro, S Adeel Hassan, A Abdul Razzack
Publikováno v:
European Journal of Preventive Cardiology. 28
Funding Acknowledgements Type of funding sources: None. Background- Recent studies have demonstrated the favorable cardiovascular outcomes of coronary artery bypass graft surgery (CABG) among patients with diabetes mellitus (DM). However, little is k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b907ce42a444e0d7b5ac4e3e87124fe1
https://doi.org/10.1093/eurjpc/zwab061.308
https://doi.org/10.1093/eurjpc/zwab061.308
Autor:
R. Garimella, K Theja Reddy, Suveenkrishna Pothuru, Surabhi Mishra, N. Shenasan, S. Abdul Razzack, O. Agolli, M. Mercedes Ferreira Caceres, D. M. Rocha Castellanos, J. Pablo Sosa, S. Mukhtar, A Abdul Razzack, Syed Adeel Hassan, A. Agolli, Kim Andrews, P. Shenasan, R. Zarrar
Publikováno v:
Annals of the Rheumatic Diseases. 80:600.1-600
Background:Type I interferons such as Anifrolumab have been implicated in Systemic lupus erythematosus (SLE) pathogenesis on the basis of increased interferon-stimulated gene expression and genetic susceptibility. Little is known regarding its effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6ffed6aad0bd67973bfd683f268a70e
https://doi.org/10.1136/annrheumdis-2021-eular.2782
https://doi.org/10.1136/annrheumdis-2021-eular.2782